WEST PALM BEACH, Fla, April 19, 2018 -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that recently announced the acquisition of its second Rural Hospital, today announces that it expects to file its full year audited financial statements for 2017 (on Form 10-K) and accompanying press release after market close on Monday April 23, 2018.
“We had previously disclosed our expectation to file this information on Tuesday April 17, 2018 but completion of our audited financial statements has taken a few days longer than expected, caused mainly by the addition of our new Hospital sector business and separation of discontinued businesses,” stated Seamus Lagan, President and Chief Executive Officer. “We look forward to disclosing our results and believe they reflect the progress we have made building our business through 2017.”
About Rennova Health, Inc.
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health
Sebastien Sainsbury, 561-666-9818
[email protected]
# # #


Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules
Mercer International Stock Surges 45% on C$20 Million Canada Funding
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
SK Hynix Shares Fall as Workers Reject Wage Deal
Luxshare Shares Rise as First-Half Profit Jumps 18%
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Google Expands Gemini Enterprise With AI Tools for Legal Sector
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Bathla Group Hires Administrators as Australia Housing Slump Deepens 



